Rich Trezza

Rich Trezza is an experienced executive in market access strategy and commercialization, currently serving as Executive Director at Vertex Pharmaceuticals since July 2021. Prior to this role, Trezza held various senior positions at Novartis, including Executive Director for both the Cellular Therapy Franchise in US Oncology and the Cardiovascular Franchise, where responsibilities included leading market access teams and developing strategic payer marketing initiatives. Trezza's career also encompasses significant leadership roles at Ogilvy Health and a range of operational roles at Novartis and other healthcare companies, highlighting expertise in managed markets, pricing strategies, and patient access services. Trezza holds a Master’s in Healthcare Administration from Seton Hall University and a Bachelor’s in Business Management from Rutgers University.